<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC4285246/results/search/funders/results.xml">
  <result pre="Dis Emerging Infect. Dis EID Emerging Infectious Diseases 1080-6040 1080-6059" exact="Centers for Disease Control and Prevention" post="pmcid: 4285246 pmid: 25529825 14-1413 doi: 10.3201/eid2101.141413 : Synopsis:"/>
  <result pre="the procedure. ‡ELISA for CCHF-specific IgM and IgG performed at the" exact="Centers for Disease Control and Prevention," post="Atlanta, Georgia, USA ( 11 ). An oral ribavirin"/>
  <result pre="(n = 74) and sent for serologic testing at the" exact="Centers for Disease Control and Prevention" post="(Atlanta, GA, USA) ( 11 ). Although baseline serologic"/>
  <result pre="of the Air Force, the Department of Defense (DoD), the" exact="Department of Health" post="and Human Services, or the United States Government. Dr."/>
  <result pre="Clin Virol. 2011; 50: 90– 2. 10.1016/j.jcv.2010.09.018 21035389 9. collab:" exact="Centers for Disease Control and Prevention" post="(CDC). Interim guidance for managing patients with suspected viral"/>
  <result pre="2005 19 May [cited 2014 Sept 11]. http://www.cdc.gov/HAI/pdfs/bbp/VHFinterimGuidance05_19_05.pdf. 10. collab:" exact="World Health Organization." post="Application for inclusion of ribavirin in the WHO model"/>
  <result pre="Infect Dis. 2009; 15: 1171– 5. 10.3201/eid1508.090015 19751577 17. collab:" exact="World Health Organization." post="Global alert and response (GAR). Ebola virus disease, West"/>
 </snippets>
</snippetsTree>
